The influence of sex and reproductive cycle on cocaine-induced behavioral and neurobiological alterations: a review

• Published in: Experimental brain research Vol. 240; no. 12; pp. 3107 - 3140
• Main Authors: dos Anjos Rosário, Barbara, de Fátima SantanaNazaré, Maria, de Souza, Daniel Vitor, Le Sueur-Maluf, Luciana, Estadella, Débora, Ribeiro, Daniel Araki, de Barros Viana, Milena
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01-12-2022; Springer; Springer Nature B.V
• Subjects: 17β-Estradiol; Amygdala; Analysis; Behavior; Biomedical and Life Sciences; Biomedicine; Care and treatment; Clinical trials; Cocaine; Drug abuse; Drug self-administration; Estrogens; Estrus cycle; Glutamic acid receptors (metabotropic); Health aspects; Hormones; Hypothalamus; Locomotion; Menstrual cycle; Neurobiology; Neurology; Neuroprotection; Neurosciences; Nucleus accumbens; Ovaries; Prefrontal cortex; Prevention; Progesterone; Psychological aspects; Review; Reviews; Risk factors; Sex; Sex factors in disease; Substance abuse; γ-Aminobutyric acid; Brazil; Cocaine; Behavior; Reproductive cycle; Sex; Neurobiology
• ISSN: 0014-4819; 1432-1106
• DOI: 10.1007/s00221-022-06479-4

This systematic review (SR) was aimed at answering two questions: (1) how sex and ovarian hormones alter behavior associated with cocaine use; (2) which possible neurobiological mechanisms explain behavioral differences. Three different researchers conducted a search in PUBMED for all kinds of articles published between the years of 1991 to 2021 on the theme "reproductive cycle and cocaine", “estrous cycle and cocaine”, “menstrual cycle and cocaine”, “fluctuation of ovarian hormones and cocaine”, “estrogen and cocaine” and “progesterone and cocaine”. Sixty original studies were identified and subdivided into experimental rodent studies and clinical trials. Experimental studies were characterized by author/year, species/strain, sex/number, age/weight, dose/route/time of administration, hormonal assessment, or administration. Clinical trials were characterized by author/year, sex/number, age, exclusion criterion, dose/route of administration/time of cocaine, and hormonal assessment. Results gathered showed that rodent females develop increased consumption, seeking behavior, craving, relapse, locomotion, increases in stress and anxiety, among other behavioral alterations during peaks of estrogen. These observations are related to the direct effects played by ovarian hormones (in particularly estradiol), in dopamine, but also in serotonin neurons, and in brain regions such as the tegmental area, the nucleus accumbens, the hypothalamus, the amygdala and the prefrontal cortex. Increased sensitization to cocaine presented by high estradiol females was linked to the activation of a CBR1-mediated mechanism and GABA-A-dependent suppression of inhibitory synaptic activity of the prelimbic prefrontal cortex. Estradiol facilitation of cocaine-increased locomotion and self-administration was shown to require the release of glutamate and the activation of metabotropic glutamate receptors subtype 5. Clinical studies also tend to point to a stimulatory effect of estradiol on cocaine sensitization and a neuroprotective effect of progesterone. In conclusion, the results of the present review indicate a need for further preclinical and clinical trials and neurobiological studies to better understand the relationship between sex and ovarian hormones on cocaine sensitization.